Gene Therapy Vector Manufacturing

Gene therapy vector manufacturing produces viral or non-viral vehicles delivering genetic material to target cells. Scalable cell culture systems generate adequate vector quantities. Purification processes concentrate viral particles removing impurities. Transduction efficiency optimisation maximises therapeutic gene delivery. Manufacturing consistency ensures stable transduction across lots.

Quality control assessments quantitate infectious units. Regulatory submissions include comprehensive vector characterisation. Manufacturing process validation confirms consistency. Scale-up from research to clinical quantities requires systematic approach. Emerging manufacturing technologies improve efficiency.